<unk>  is active against many bacteria including susceptible strains of Staphylococci and Streptococci, as well as a range of gram negative organisms. As with the other cephalosporins, it is susceptible to beta-lactamase, although as a second-generation variety, it is less so. Hence, it may have greater activity against Haemophilus influenzae, Neisseria gonorrhoeae, and Lyme disease. Unlike other second-generation cephalosporins,<unk>  can cross the blood-brain barrier. A systematic review found high quality evidence that injecting the eye with<unk>  after cataract surgery will lower the chance of developing endophthalmitis after surgery.
Cefuroxime
Meropenem
Cefepime
Vancomycin
Aztreonam
Levofloxacin
Cefazolin
Imipenem